ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.405,64
-1,10%
S&P 500
5.291,34
0,15%
Dow Jones
38.711,29
0,36%
Euro vs US Dollar
1,08787
-0,03%
Bitcoin
70.596,48
0,04%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Nexmed (MM) (NEXM)

  7. Nexmed (MM) (NEXM) News

NEXM

Nexmed (MM) (NEXM)

Nexmed (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NEXM
DatumZeitQuelleÜberschriftSymbolFirma
10/09/201023h11Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
10/09/201022h31Business WireNexMed, Inc. Announces Results of Special Meeting of Stockholders, Including Name Change to Apricus BiosciencesNASDAQ:NEXMNexmed (MM)
31/08/201023h18Edgar (US Regulatory)Securities Registration Statement (S-1)NASDAQ:NEXMNexmed (MM)
25/08/201017h00Business WireNexMed To Present at the Rodman & Renshaw 12th Annual Healthcare ConferenceNASDAQ:NEXMNexmed (MM)
23/08/201015h00Business WireNexMed Receives Additional Patent Coverage for IsraelNASDAQ:NEXMNexmed (MM)
19/08/201023h20Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
17/08/201012h03Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:NEXMNexmed (MM)
12/08/201023h10Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:NEXMNexmed (MM)
11/08/201015h15Business WireNexMed Announces 2010 Second Quarter Financial Results Conference CallNASDAQ:NEXMNexmed (MM)
06/08/201020h34Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:NEXMNexmed (MM)
26/07/201018h36Business WireMohamed Hachicha, Ph.D. Joins NexMed, Inc. as Vice President-Research and Development for NexMed, USANASDAQ:NEXMNexmed (MM)
21/06/201015h15GlobeNewswire Inc.Emerging Stock Report Initiates Independent Research Coverage on NexMed, Inc.NASDAQ:NEXMNexmed (MM)
17/06/201023h05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
15/06/201020h48Business WireNexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation is Bioeq...NASDAQ:NEXMNexmed (MM)
15/06/201015h20Business WireNexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation is Bioeq...NASDAQ:NEXMNexmed (MM)
10/06/201019h30Business WireNexMed Provides Update on Canadian Filing for Vitaros®NASDAQ:NEXMNexmed (MM)
27/05/201019h16Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
27/05/201000h24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NEXMNexmed (MM)
26/05/201021h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NEXMNexmed (MM)
25/05/201023h00Business WireNexMed Announces Expansion of Senior Business Development TeamNASDAQ:NEXMNexmed (MM)
17/05/201023h11Business WireNexMed to Discuss P2/3 Protocol for NexACT®-Based Alprostadil Treatment for Raynaud’s Syndrome with the FDANASDAQ:NEXMNexmed (MM)
13/05/201023h09Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:NEXMNexmed (MM)
12/05/201023h01Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
12/05/201022h30Business WireNexMed Announces Pre-Clinical Study Showing Vitaros® Significantly Promotes Wound HealingNASDAQ:NEXMNexmed (MM)
10/05/201023h19Business WireNexMed Announces Encouraging Pre-Clinical Results Showing the Ability of the NexACT® Technology to Enhance the Bioavailabili...NASDAQ:NEXMNexmed (MM)
07/05/201011h50GlobeNewswire Inc.BioTech Stock Alert for NexMed Inc. Issued by MicroStockProfitNASDAQ:NEXMNexmed (MM)
06/05/201022h45Business WireNexMed Expands Scientific Advisory Board with Appointment of Key Industry LeadersNASDAQ:NEXMNexmed (MM)
05/05/201022h36Business WireNexMed Announces Patent Allowance for NexACT® in CanadaNASDAQ:NEXMNexmed (MM)
30/04/201020h53Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:NEXMNexmed (MM)
29/04/201012h06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
 Showing the most relevant articles for your search:NASDAQ:NEXM

Kürzlich von Ihnen besucht

CCOM
US100
US Tech 100
NASDAQ
NVDA
NVIDIA
USOTC
BNPQY
BNP Paribas (QX)
COIN
BTCUSD
Bitcoin
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BASFY
BASF (QX)
DBI
TDXP
Tec DAX
TG
DBK
Deutsche Bank
AMEX
SPY
SPDR S&P 500
NASDAQ
GOOGL
Alphabet
NASDAQ
TSLA
Tesla
AMEX
XLF
Financial Select Sector
NASDAQ
MSFT
Microsoft
USOTC
RHHBY
Roche (QX)
FX
EURUSD
Euro vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten